ArticleJournal of endocrinological investigation2015

Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients.

G T Russo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.